openPR Logo
Press release

Lawsuit filed for certain Investors who lost money with shares of Cutera, Inc. (NASDAQ: CUTR)

06-01-2023 12:25 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A lawsuit was filed on behalf of investors in Cutera, Inc. (NASDAQ: CUTR) shares over alleged securities laws violations.

A lawsuit was filed on behalf of investors in Cutera, Inc. (NASDAQ: CUTR) shares over alleged securities laws violations.

An investor, who purchased shares of Cutera, Inc. (NASDAQ: CUTR), filed a lawsuit over alleged violations of Federal Securities Laws by Cutera, Inc..

Investors who purchased shares of Cutera, Inc. (NASDAQ: CUTR) have certain options and for certain investors are short and strict deadlines running. Deadline: July 24, 2023. NASDAQ: CUTR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Brisbane, CA based Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide.

On January 9, 2023, Cutera, Inc reported its preliminary financial results for full year 2022, including the fact that Cutera had failed to meet its revenue guidance for 2022.

On February 28, 2023, Cutera Inc announced, that it would fail to file its 2022 annual report in a timely manner. The Company also admitted that it identified "material weaknesses in its internal control over financial reporting related to ineffective information technology general controls and ineffective inventory count controls."

On March 16, 2023, Cutera, Inc announced that it would not meet the extended deadline for filing its 2022 annual report, and would endeavor to file its 2022 annual report "as soon as practicable." The company also revealed that, in addition to the material weaknesses previously identified, Cutera, Inc had identified material weaknesses related to stock-based compensation.

On March 24, 2023, Cutera disclosed that Nasdaq notified the company that it was "not in compliance with Nasdaq Listing Rule 5250(c)(1)" for failing to timely file its 2022 annual financial report. On this news, the price of Cutera common stock declined $0.92 per share, or approximately 3.4%, from a close of $27.07 per share on March 24, 2023, to close at $26.15 per share on March 27, 2023.

On April 7, 2023, Cutera, Inc. disclosed that the company's Executive Chairman and Chairman of the Board, Defendant J. Daniel Plants ("Plants"), demanded a special meeting of the company's stockholders to vote on the removal of five members of the Board.

On April 10, 2023, Plants and David H. Mowry ("Mowry"), the company's Chief Executive Officer, issued statements in support of their separate demands calling for the Board to remove five of its directors. In connection with their demands, Plants and Mowry cited concerns that the Board had not made progress on a succession plan for the role of Chief Executive Officer, and Mowry stated that "the approach the Entrenched Directors have taken to these matters has been detrimental to the business and served no purpose other than to position certain Directors closer to the CEO title that they seem to covet for themselves."

Then, on April 12, 2023, Cutera, Inc. revealed that it had terminated Plants as the company's Executive Chairman and Chairman of the Board and Mowry as Chief Executive Officer, appointing current Board members Janet D. Widmann and Sheila A. Hopkins as Independent Chair of the Board and Interim Chief Executive Officer, respectively. In connection with this announcement, Cutera, Inc. also formally withdrew its full year 2023 financial guidance.

Then, on May 9, 2023, Cutera, Inc. reported its financial results for the first quarter 2023 that were "below expectations due to execution challenges in the business" and announced that Rohan Seth had resigned as the company's Chief Financial Officer.

Shares of Cutera, Inc. (NASDAQ: CUTR) declined from $74.38 per share on April 05, 2022, to as low as $13.21 per share on May 12, 2023.

The plaintiff claims that between February 17, 2021, and May 9, 2023, the Defendants overstated the sustainability of Cutera's revenue growth, failed to disclose significant conflicts among members of the company's senior leadership and Board, and failed to disclose several material weaknesses in Cutera's internal control over financial reporting and that as a result of Defendant's wrongful acts and omissions, and the significant decline in the market value of the company's common stock, Cutera's investors have suffered significant damages.

Those who purchased shares of Cutera, Inc. (NASDAQ: CUTR) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lawsuit filed for certain Investors who lost money with shares of Cutera, Inc. (NASDAQ: CUTR) here

News-ID: 3074009 • Views:

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) over possible Violations of Securities Laws
Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NA …
An investigation was announced for investors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) shares over potential securities laws violations by Lifecore Biomedical, Inc. Investors who purchased shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Lifecore Biomedical, Inc. regarding its business, its prospects and
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: DBI) over potential Wrongdoing by certain directors
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: D …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Designer Brands Inc. Investors who purchased shares of Designer Brands Inc. (NYSE: DBI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Designer Brands Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Columbus,
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. …
An investor, who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ), filed a lawsuit over alleged violations of Federal Securities Laws by Innoviz Technologies Ltd. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) have certain options and for certain investors are short and strict deadlines running. Deadline: May 14, 2024. NASDAQ: INVZ investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NASDAQ: IRBT)
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NA …
An investor, who purchased shares of iRobot Corporation (NASDAQ: IRBT), filed a lawsuit over alleged violations of Federal Securities Laws by iRobot Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of iRobot Corporation (NASDAQ: IRBT) have certain options and for certain investors are short and strict deadlines running. Deadline: May 7, 2024. NASDAQ: IRBT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)

All 5 Releases


More Releases for Cutera

Microneedling Market Positive Demand Outlook, Supportive Valuations | Lumenis, C …
Global Microneedling Market Size study, by Type (Laser, RF) Product (Derma-stamp, dermapen, dermarollers) Needle Material (Silicon, Metal, Glass Hollow) Application (Skin Rejuvenation, Acne Scar, Traumatic & Surgical Scars, Others) and Regional Forecasts 2021-2027, The ' Microneedling market' research report added by Report Ocean, is an in-depth analysis of the latest developments, market size, status, upcoming technologies, industry drivers, challenges, regulatory policies, with key company profiles and strategies of players. The
Porokeratosis Treatment Market Boosting the Growth Worldwide | Almirall, Pfizer, …
The latest study released on the Global Porokeratosis Treatment Market by AMA Research evaluates market size, trend, and forecast to 2027. The Porokeratosis Treatment market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key Players in
Laser Therapy Market 2021-Angiodynamics, Biolase, Valeant, IRIDEX, Cutera
It is our aim to provide our readers with report for Laser Therapy Market, which examines the industry during the period 2021 – 2027. One goal is to present deeper insight into this line of business in this document. The first part of the report focuses on providing the industry definition for the product or service under focus in the Laser Therapy Market report. Next, the document will study the
Global Tattoo Removal Market 2020 : Cutera, Cynosure, Lumenis
The research report "Tattoo Removal Market: Global and Regional Analysis 2019 – 2024" discover accurate information about the long run prospects of this Tattoo Removal market, which can help industry players to understand the flow of the market throughout the period 2019-2024. The global Tattoo Removal market has defined the market scenario in an orderly way, emphasizing the industrial development, prominent players engaged from the current Tattoo Removal market, chapter
Medical aesthetics device Market 2019 By Key Players: Photomedex, Cutera, Cynosu …
Medical aesthetics device Market report represent market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. Download PDF Sample of this Report @ http://www.supplydemandmarketresearch.com/home/contact/50951?ref=Sample-and-Brochure&toccode=SDMRMA50951&utm_source=S2 The following manufacturers are covered: Photomedex
2019 Medical Aesthetics Device Market | By Key Players: Photomedex ,Cutera, Cyno …
Medical Aesthetics Device Market report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and